Clinical Trial Update: Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD

View source ↗

Summary

A clinical trial is evaluating posaconazole tablets as primary prophylaxis against invasive fungal disease in hematopoietic stem cell transplant recipients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematopoietic Stem Cell Transplantation
• Invasive Fungal Disease

Drugs mentioned

• Posaconazole Tablet (posaconazole)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Invasive Fungal Disease, Graft Versus Host Disease | Status: ENROLLING_BY_INVITATION